The use of systemic steroids in otolaryngology

Ear, Nose and Throat Journal

Volumn 75, Issue 8, 1996, Pages

  Nadel, Douglas M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ARTICLE; CUSHING SYNDROME; DRUG USE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NERVE INJURY; OSTEOPOROSIS; OTORHINOLARYNGOLOGY; STEROID THERAPY;

EID: 9444288676     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139607500809     Document Type: Article

References (57)

1. Streeton DHP. Corticosteroid therapy: Pharmacological properties and principles of corticosteroid use. JAMA 1975; 232:944-7.
2. Williams GH, Dluhy RG. Diseases of the adrenal cortex, in Harrison's Principles of Internal Medicine, 13th ed. New York, McGraw-Hill, 1994; 1953-76.
3. Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, 8th ed. Philadelphia, WB Saunders, 1992.
4. Melby JC. Systemic corticosteroid therapy: Pharmacology and endocrinologic considerations. Ann Intern Med 1974; 81:505-12.
5. Hall ED. Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell Molec Neurobiol 1993; 13:415-32.
6. McEvoy GK (ed): AHFS Drug Information 1995. Bethesda, MD, American Society of Health-System Pharmacists, 1995.
7. Gilman AG, et al (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 6th ed. New York, Macmillan, 1980.
8. Laan R, et al. Vertebral osteoporosis in rheumatoid arthritis patients: Effects of low dose prednisone therapy. Br J Rheumatol 1992; 31:91-6.
9. Johnston CC, Slemenda CW, Meltoo LJ. Clinical use of bone densitometry. N Engl J Med 1991; 24:1105-9.
10. Whitworth JA. Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int 1992; 41(Suppl 37):34-7.
11. Dekhuijzen PNR, Decramer M. Steroid-induced myopathy and its significance to respiratory disease: A known disease rediscovered. Eur Respir J 1992; 5:997-1003.
12. Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin 1992; 10:505-12.
13. Allen MB, Ray SG, Leitch AG, et al. Steroid aerosols and cataract formation. Br Med J 1989; 299:432.
14. Coombs RRH, Thomas R. A vascular necrosis of the hip. Brit J Hosp Med 1994; 51:275-80.
15. Desforges J. Current concepts in osteonecrosis. N Engl J Med 1991; 22:1473.
16. Kennedy DW. Personal communication, June 1995.
17. Mabry R. Corticosteroids in rhinology, in Goldman (ed): The Principles and Practice of Rhinology. New York, John Wiley, 1987.
18. Derebery M. Otolaryngic allergy. Oto Clin N Am 1993; 26:593-611.
19. Harter JG, Reddy WJ, Thorn GW. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963; 269:591.
20. Webb DR. Steroids in allergic disease. Med Clin N Am 1981; 65:1073-81.
21. Salassa RM, Bennet WA, Keating FR. Postoperative adrenal cortical insufficiency; occurrence in patients previously treated with cortisone. JAMA 1953; 152:1509-15.
22. Feely J. Drugs and the endocrine system, in Wood and Wood (eds): Drugs and Anesthesia: Pharmacology for Anesthesiologists. Baltimore, Williams and Wilkins Co., 1982; 604-7.
23. Michels MI, Smith RE, Heimlich EM. Adrenal suppression and intranasally applied steroids. Ann Allergy 1967; 25:569-74.
24. Katzenstein A-L, Sale SR, Greenberger PA. Allergic aspergillus sinusitis: A newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72:89-93.
25. Safirstein B, D'Souza M, Simon G, et al. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973; 108:450-9.
26. Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Oto HNS 1994; 111:580-8.
27. Manning SC, Schaefer SD, Close LG, et al. Culture-positive allergic fungal sinusitis. Arch Otolaryngol 1991, 117:174-8.
28. Waxman JE, Spector JG, Sale SR, et al. Allergic aspergillus sinusitis: Concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987; 97:261-6.
29. Allphin AL, Strauss M, Abdul-Karim FW. Allergic fungal sinusitis: Problems in diagnosis and treatment. Laryngoscope 1991; 101:815-20.
30. Taverner D. Cortisone treatment of Bell's palsy. Lancet 1954; 2:1052-6.
31. Stankiewicz JA. Steroids and idiopathic facial paralysis. Oto HNS 1983; 91:672-7.
32. Stankiewicz JA. A review of the published data on steroids and idiopathic facial paralysis. Oto HNS 1987; 97:481-6.
33. Wolf SM. Treatment of Bell's palsy with prednisone. A prospective randomized study. Neurology 1978; 28:158-61.
34. Austin JR, Peskind SP, Austin SG, et al. Idiopathic facial nerve paralysis: A randomized double blind controlled study of placebo versus prednisone. Laryngoscope 1993; 103:1326-33.
35. Hughes GB. Practical management of Bell's palsy. Oto HNS 1990; 102:658-63.
36. Adour K. Corticosteroid therapy for acute facial paralysis, in Snow J (ed): Controversies in Otolaryngology. Philadelphia, WB Saunders, 1980; 395-400.
37. Neely JG. Idiopathic facial paralysis, in Gates GA (ed): Current Therapy in Otolaryngology - Head and Neck Surgery, 1982-3. St. Louis, Mosby, 1982; 73-6.
38. Gates GA. Personal communication, February 1995.
39. Grandis JR, Hirsch BE, Wagener MM. Treatment of idiopathic sudden sensorineural hearing loss. Am J Otol 1993; 14:183-5.
40. Wilson WR, Byl FM, Laird N. Efficacy of steroids in the treatment of idiopathic sudden hearing loss: A double-bind clinical study. Arch Otolaryngol 1980; 106:772-6.
41. Moskowitz D, et al. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984; 94:664-6.
42. McCabe BF. Autoimmune ear disease: Therapy. Am J Otol 1989; 10:196-7.
43. Shea JJ. Autoimmune sensorineural hearing loss as an aggravating factor in Maniere's disease. Adv Otorhinolaryngol 1983; 30:254-7.
44. Suzuki M, Kitahara M. Immunologic abnormality in Meniere's disease. Oto HNS 1992; 107:57-62.
45. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88:585-9.
46. Atkinson JP. Diagnosis and management of hereditary angioedema. Ann Allergy 1979; 42:348-52.
47. Hawkins DB. Corticosteroids in the management of laryngotracheobronchitis. Otorhinolaryngol Head Neck Surg 1980; 88:207-10.
48. Hawkins DB, Shum TK, Crockett DM. Corticosteroids in otolaryngology, in Collins S (ed): Pharmacology in Otolaryngology - Head and Neck Surgery. Washington, DC, American Academy of Otolaryngology - Head and Neck Surgery Foundation, Inc., 1987; 30-50.
49. Koren G, et al. Corticosteroid treatment of laryngotracheitis versus spasmodic croup in children. Am J Dis Child 1983; 137:941.
50. Postma DS, Jones RO, Pillsbury HC. Severe hospitalized croup: Treatment trends and prognosis. Laryngoscope 1984; 94:1170.
51. Catlin FI, Grimes WJ. The effect of steroid therapy on recovery from tonsillectomy in children. Arch Oto HNS 1991; 117:649-52.
52. Volk MS, Martin P, Brodsky L, et al. The effects of preoperative steroids on tonsillectomy patients. Oto HNS 1993; 109:726-30.
53. Holinger LD, Tucker GF. In Cummings, et al (eds): Trauma, in Otolaryngology - Head and Neck Surgery, 2nd ed. St. Louis, Mosby Year Book, 1993.
54. Hawkins DB, Demeter MJ, Barnett TE. Caustic ingestion: Controversies in management. Laryngoscope 1980; 90:98-109.
55. Wald ER, Kaplan SL, Mason EO, et al. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995; 95:21-32.
56. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324:1525-31.
57. Dexamethasone therapy for bacterial meningitis in infants and children, in Report of the Committee on Infectious Diseases of the American Academy of Pediatrics, 23rd ed. Elk Grove Village, IL, American Academy of Pediatrics, 1994; 558-9.